Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations - Quiz - MDSpire

Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations

  • By

  • Wei Li

  • Hui Xu

  • July 14, 2026

Share

Original Source(s)

Related Content